Qianqian Nie

Xuzhou, 221116, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Dual Z-scheme g-C3N4/GQD/ZnIn2S4 composites with enhanced photocatalytic degradation of xanthate under visible light irradiation.

Dual Z-scheme g-C3N4/GQD/ZnIn2S4 composites with enhanced photocatalytic degradation of xanthate under visible light irradiation.

Journal: Nanoscale

Published: May 29, 2026

Association of peripheral insulin resistance with cognitive impairment in patients with non-disabling ischemic cerebrovascular events and the mediating role of chronic inflammatory biomarkers.

Association of peripheral insulin resistance with cognitive impairment in patients with non-disabling ischemic cerebrovascular events and the mediating role of chronic inflammatory biomarkers.

Journal: European journal of medical research

Published: November 06, 2025

Visible-Light-Driven Photocatalytic Degradation of Xanthate in Flotation by g-C3N4/ZnIn2S4 Heterojunction: Experimental and DFT Studies.

Visible-Light-Driven Photocatalytic Degradation of Xanthate in Flotation by g-C3N4/ZnIn2S4 Heterojunction: Experimental and DFT Studies.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: April 30, 2025

Lipocalin 2 Facilitates the Initial Compromise of the Blood-Brain Barrier Integrity in Chronic Cerebral Hypoperfusion.

Lipocalin 2 Facilitates the Initial Compromise of the Blood-Brain Barrier Integrity in Chronic Cerebral Hypoperfusion.

Journal: CNS neuroscience & therapeutics

Published: January 24, 2025

Micro-Spherical BiOI Photocatalysts for Efficient Degradation of Residual Xanthate and Gaseous Nitric Oxide.

Micro-Spherical BiOI Photocatalysts for Efficient Degradation of Residual Xanthate and Gaseous Nitric Oxide.

Journal: Nanomaterials (Basel, Switzerland)

Published: December 28, 2023

Lysyl oxidase-like 1 predicts the prognosis of patients with primary glioblastoma and promotes tumor invasion via EMT pathway.

Lysyl oxidase-like 1 predicts the prognosis of patients with primary glioblastoma and promotes tumor invasion via EMT pathway.

Journal: PeerJ

Published: November 30, 2023

Different doses of Rituximab for the therapy of Neuromyelitis optica spectrum disorder: A systematic review and meta-analysis.

Different doses of Rituximab for the therapy of Neuromyelitis optica spectrum disorder: A systematic review and meta-analysis.

Journal: Multiple sclerosis and related disorders

Published: May 18, 2022

Synaptotagmin-3 interactions with GluA2 mediate brain damage and impair functional recovery in stroke.

Synaptotagmin-3 interactions with GluA2 mediate brain damage and impair functional recovery in stroke.

Journal: Cell reports

Published: March 12, 2022

Showing 1-8 of 8

Last Updated: 09/26/2026